Alexander Bedenkov, MD, PhD

The need to look beyond the function’s traditional performance measures to the one that really matters-patient outcomes.

A description of the changing role of the medical affairs function in pharmaceutical companies and the subsequent evolution to a never ending measurement of the output of medical affairs. How to overcome this quest for sometimes meaningless numbers to justify its existence.